Example logo GIS 26

Global Innovation Summit 2026

6 May 2026 | Basel, Switzerland

Home

Trisail Medical

SME

www.trisailmedical.com/Singapore, Singapore
5 profile visits

About

Trisail Medical, a spin-off from the National Heart Centre Singapore, is developing the world's simplest and fastest transcatheter medical device to treat tricuspid regurgitation, a heart valve disease affecting >60 million people globally. The company has strong pre-clinical safety data and is raising Series A financing to complete First-in-Human studies. We welcome potential investors and collaborators who wish to learn more about our technology and company to reach out and discuss the opportunity.

What is your business/industry sector?

Healthcare

Representatives

Srinivas Bhylahalli

CEO

Trisail Medical

Marketplace (1)

  • Project cooperation

    Development and testing of novel heart valve repair device

    Trisail Medical is developing a novel transcatheter tricuspid valve repair device. We welcome partners with interest in cardiac implant/heart valve area. Opportunity for joint product development, testing,clinical development, grants funding & licensing.

    • Execution
    • Technical
    • Healthcare
    • EU projects
    • Biotech, Pharma and Cosmetics
    Author

    Srinivas Bhylahalli

    CEO at Trisail Medical

    Singapore, Singapore